Skip to main content
Premium Trial:

Request an Annual Quote

UK's BBSRC Earmarks Cash for Bioinformatics Resources, Systems Bio Tools

NEW YORK (GenomeWeb News) —The UK’s Biotechnology and Biological Sciences Research Council this week issued two calls for proposals of interest to bioinformatics.
The first, “Bioinformatics and Biological Resources Fund,” has set aside £6 million ($11.4 million) for a pilot project “to support the establishment, maintenance, and enhancement of bioinformatic and biological resources required by bioscience communities.”
The fund will support “high quality, strategically relevant” resources that are “necessary to underpin the UK's international quality bioscience.” Grants are available for up to five years. BBSRC said it expects to award grants across a range of £50,000 to £1.5 million.
The closing date for expressions of interest is Dec. 15. Further information on the initiative is available here.
The second proposal, “Research Networks: Mathematical Tools for Systems Biology,” will provide £400,000 over three years to support up to six research networks “that will bring together mathematical scientists and life scientists in order to tackle key challenges in systems biology.”
Each network will focus on a different area of the “mathematics/systems biology interface,” BBSRC said.
The closing date for proposals is March 7, 2007. Further details are available here.

Filed under

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.